Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Concert Pharmaceuticals hired James Shipley as chief medical officer. Previously, he was was senior vp of clinical development, medical and regulatory affairs at Indevus Pharmaceuticals, which is now owned by Endo Pharmaceuticals, and before that, he was senior vp of clinical research at Praecis Pharmaceuticals.

Karuna Pharmaceuticals hired Ed Harrigan as ceo;
Penn Pharma hired Ed Rowland to head operational analytical services;
Momenta Pharmaceuticals added Thomas Koestler to its board;
Jennerex hired Ursula Fritsch as vp regulatory affairs;
Human Genome Sciences added Greg Norden to its board;
Alkermes added Wendy Dixon to its board;
PharmaForm hired Blair West as vp of pharmaceutical operations;
QPharma hired Dave Hammond as vp of sales and marketing;
NDA Group hired Thomas Lönngren from the European Medicines Agency;
Roche named Alan Frippe as cfo;
ImmunoGen named Theresa Wingrove as vp of regulatory affairs;
Concert Pharmaceuticals promoted Robert Silverman to sr vp & general counsel;
Cetero Research hired Roger Hays as president of bioanalytical operations;
Consumer Healthcare Products Assocation named Emily Skor as vp communications;
Foundation Medicine hired Gary Palmer as sr vp medical affairs & commercial development;
Optimer Pharmaceuticals hired Linda Amper as sr vp human resources;
Optimer Pharmaceuticas hired Hemal Shah as sr vp health, economics & outcomes research;
Optimer Pharmaceuticals hired John Womelsdorf as vp business development;